Patient-Specific Induced Pluripotent Stem Cell Models: Characterization of iPS Cell-Derived Cardiomyocytes

Toru Egashira, Shinsuke Yuasa, Shugo Tohyama, Yusuke Kuroda, Tomoyuki Suzuki, Tomohisa Seki, Keiichi Fukuda

Research output: Chapter in Book/Report/Conference proceedingChapter

4 Citations (Scopus)

Abstract

Despite significant advances in medical treatment, cardiovascular disease is still a major cause of morbidity and mortality in advanced countries. To improve the outcome, the further promotion of basic cardiovascular science has a pivotal role for the developing novel therapeutic approach. However, due to the inaccessibility of human heart tissue, we couldn’t obtain the sufficient amount of patient’s heart tissues. The discovery of human-induced pluripotent stem cells (iPSCs) is highly expected to provide the breakthrough to this obstruction. Through the patient-specific iPSCs-derived cardiomyocytes, we could analyze the patient-specific heart diseases directly and repetitively. Herein we introduce the outline of creation for cardiac disease modeling using patient-specific iPSCs.Within several topics, we present the actual representative methodologies throughout the process from the derivation of cardiomyocytes to those of functional analysis.

Original languageEnglish
Title of host publicationMethods in Molecular Biology
PublisherHumana Press Inc.
Pages343-353
Number of pages11
Volume1353
DOIs
Publication statusPublished - 2016

Publication series

NameMethods in Molecular Biology
Volume1353
ISSN (Print)10643745

Fingerprint

Induced Pluripotent Stem Cells
Cardiac Myocytes
Heart Diseases
Cardiovascular Diseases
Morbidity
Mortality
Therapeutics

Keywords

  • Cardiomyocyte
  • Electrophysiology
  • IPS cell
  • Purification

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics

Cite this

Egashira, T., Yuasa, S., Tohyama, S., Kuroda, Y., Suzuki, T., Seki, T., & Fukuda, K. (2016). Patient-Specific Induced Pluripotent Stem Cell Models: Characterization of iPS Cell-Derived Cardiomyocytes. In Methods in Molecular Biology (Vol. 1353, pp. 343-353). (Methods in Molecular Biology; Vol. 1353). Humana Press Inc.. https://doi.org/10.1007/7651_2014_165

Patient-Specific Induced Pluripotent Stem Cell Models : Characterization of iPS Cell-Derived Cardiomyocytes. / Egashira, Toru; Yuasa, Shinsuke; Tohyama, Shugo; Kuroda, Yusuke; Suzuki, Tomoyuki; Seki, Tomohisa; Fukuda, Keiichi.

Methods in Molecular Biology. Vol. 1353 Humana Press Inc., 2016. p. 343-353 (Methods in Molecular Biology; Vol. 1353).

Research output: Chapter in Book/Report/Conference proceedingChapter

Egashira, T, Yuasa, S, Tohyama, S, Kuroda, Y, Suzuki, T, Seki, T & Fukuda, K 2016, Patient-Specific Induced Pluripotent Stem Cell Models: Characterization of iPS Cell-Derived Cardiomyocytes. in Methods in Molecular Biology. vol. 1353, Methods in Molecular Biology, vol. 1353, Humana Press Inc., pp. 343-353. https://doi.org/10.1007/7651_2014_165
Egashira T, Yuasa S, Tohyama S, Kuroda Y, Suzuki T, Seki T et al. Patient-Specific Induced Pluripotent Stem Cell Models: Characterization of iPS Cell-Derived Cardiomyocytes. In Methods in Molecular Biology. Vol. 1353. Humana Press Inc. 2016. p. 343-353. (Methods in Molecular Biology). https://doi.org/10.1007/7651_2014_165
Egashira, Toru ; Yuasa, Shinsuke ; Tohyama, Shugo ; Kuroda, Yusuke ; Suzuki, Tomoyuki ; Seki, Tomohisa ; Fukuda, Keiichi. / Patient-Specific Induced Pluripotent Stem Cell Models : Characterization of iPS Cell-Derived Cardiomyocytes. Methods in Molecular Biology. Vol. 1353 Humana Press Inc., 2016. pp. 343-353 (Methods in Molecular Biology).
@inbook{8a277b5d3ab549a9be8f7324c53afe30,
title = "Patient-Specific Induced Pluripotent Stem Cell Models: Characterization of iPS Cell-Derived Cardiomyocytes",
abstract = "Despite significant advances in medical treatment, cardiovascular disease is still a major cause of morbidity and mortality in advanced countries. To improve the outcome, the further promotion of basic cardiovascular science has a pivotal role for the developing novel therapeutic approach. However, due to the inaccessibility of human heart tissue, we couldn’t obtain the sufficient amount of patient’s heart tissues. The discovery of human-induced pluripotent stem cells (iPSCs) is highly expected to provide the breakthrough to this obstruction. Through the patient-specific iPSCs-derived cardiomyocytes, we could analyze the patient-specific heart diseases directly and repetitively. Herein we introduce the outline of creation for cardiac disease modeling using patient-specific iPSCs.Within several topics, we present the actual representative methodologies throughout the process from the derivation of cardiomyocytes to those of functional analysis.",
keywords = "Cardiomyocyte, Electrophysiology, IPS cell, Purification",
author = "Toru Egashira and Shinsuke Yuasa and Shugo Tohyama and Yusuke Kuroda and Tomoyuki Suzuki and Tomohisa Seki and Keiichi Fukuda",
year = "2016",
doi = "10.1007/7651_2014_165",
language = "English",
volume = "1353",
series = "Methods in Molecular Biology",
publisher = "Humana Press Inc.",
pages = "343--353",
booktitle = "Methods in Molecular Biology",

}

TY - CHAP

T1 - Patient-Specific Induced Pluripotent Stem Cell Models

T2 - Characterization of iPS Cell-Derived Cardiomyocytes

AU - Egashira, Toru

AU - Yuasa, Shinsuke

AU - Tohyama, Shugo

AU - Kuroda, Yusuke

AU - Suzuki, Tomoyuki

AU - Seki, Tomohisa

AU - Fukuda, Keiichi

PY - 2016

Y1 - 2016

N2 - Despite significant advances in medical treatment, cardiovascular disease is still a major cause of morbidity and mortality in advanced countries. To improve the outcome, the further promotion of basic cardiovascular science has a pivotal role for the developing novel therapeutic approach. However, due to the inaccessibility of human heart tissue, we couldn’t obtain the sufficient amount of patient’s heart tissues. The discovery of human-induced pluripotent stem cells (iPSCs) is highly expected to provide the breakthrough to this obstruction. Through the patient-specific iPSCs-derived cardiomyocytes, we could analyze the patient-specific heart diseases directly and repetitively. Herein we introduce the outline of creation for cardiac disease modeling using patient-specific iPSCs.Within several topics, we present the actual representative methodologies throughout the process from the derivation of cardiomyocytes to those of functional analysis.

AB - Despite significant advances in medical treatment, cardiovascular disease is still a major cause of morbidity and mortality in advanced countries. To improve the outcome, the further promotion of basic cardiovascular science has a pivotal role for the developing novel therapeutic approach. However, due to the inaccessibility of human heart tissue, we couldn’t obtain the sufficient amount of patient’s heart tissues. The discovery of human-induced pluripotent stem cells (iPSCs) is highly expected to provide the breakthrough to this obstruction. Through the patient-specific iPSCs-derived cardiomyocytes, we could analyze the patient-specific heart diseases directly and repetitively. Herein we introduce the outline of creation for cardiac disease modeling using patient-specific iPSCs.Within several topics, we present the actual representative methodologies throughout the process from the derivation of cardiomyocytes to those of functional analysis.

KW - Cardiomyocyte

KW - Electrophysiology

KW - IPS cell

KW - Purification

UR - http://www.scopus.com/inward/record.url?scp=84946781964&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84946781964&partnerID=8YFLogxK

U2 - 10.1007/7651_2014_165

DO - 10.1007/7651_2014_165

M3 - Chapter

C2 - 25520287

AN - SCOPUS:84946781964

VL - 1353

T3 - Methods in Molecular Biology

SP - 343

EP - 353

BT - Methods in Molecular Biology

PB - Humana Press Inc.

ER -